Funding news
Paralos Bioscience Inc. logo

Paralos Bioscience Inc. Raises $64

Recently funded · $646.9K SeedHospitals and Health CareUSView source

Get the full Paralos Bioscience Inc. company profile

Access contacts, investors, buying signals & more

Open in Dashboard

A new approach to drug delivery, one that promises to tackle some of the most pressing global healthcare challenges, just got a financial boost. Paralos Bioscience Inc., the biotechnology company behind a first-in-class phage-drug conjugate platform technology, has successfully closed a seed round, raising $647K.

The fresh capital is earmarked to accelerate the development of its innovative drug delivery system. Paralos Bioscience's unique platform aims to enhance the efficacy and precision of treatments, marking an early but significant step for the company in the competitive biotech landscape.

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Seed rounds

Companies that recently closed a Seed round.

#CompanyAmount
1
Tombot logo

Tombot

United States

$7.0M
2
Syntax Bio logo

Syntax Bio

United States

$14.4M
3
Tripay logo

Tripay

United States

$52.0K
4
BlueFletch logo

BlueFletch

United States

$225.0K
5
Virbela logo

Virbela

$800.0K